title: Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma.
authors: Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain emocio@usal.es.
authors: Enrique M
authors: EM
authors: Ocio
authors: Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
authors: Julio
authors: J
authors: Dávila
authors: Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
authors: Juan-Carlos
authors: JC
authors: Caballero
authors: Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
authors: Sara
authors: S
authors: Alonso
authors: Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
authors: Verónica González
authors: VG
authors: de la Calle
authors: Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
authors: Ramón
authors: R
authors: García-Sanz
authors: Novartis Pharmaceuticals, Basel, Switzerland.
authors: Lucien
authors: L
authors: Gazi
authors: Novartis Pharmaceuticals, Basel, Switzerland.
authors: Socrates
authors: S
authors: Opio
authors: Novartis Pharmaceuticals, Basel, Switzerland.
authors: Mónica
authors: M
authors: Jiménez
authors: Clínica Universidad de Navarra, Centro de Investigaciones Médicas Aplicadas (CIMA-IDISNA), Pamplona, Spain.
authors: Jesús F
authors: JF
authors: San-Miguel
authors: Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
authors: María-Victoria
authors: MV
authors: Mateos
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069286:Bortezomib / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D000077767:Panobinostat; D012008:Recurrence
chemical_list: D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D007211:Indoles; D000069286:Bortezomib; D003907:Dexamethasone; D000077767:Panobinostat
keywords: maintenance; panobinostat; progression-free survival; relapsed multiple myeloma